Journal of the Egyptian National Cancer Institute (Apr 2024)

A comparative study in left-sided breast cancer treated with moderate deep inspiratory breath hold versus free breathing

  • Anupam Muraleedharan,
  • Sandip Kumar Barik,
  • Deepak Kumar Das,
  • Saroj Kumar Das Majumdar,
  • Bikash Ranjan Mahapatra,
  • Bijay Kumar Barik,
  • Mathan Kumar Ramasubbu,
  • Nehla Haroon K. M.,
  • Poornima Devi U.,
  • Sk Soel Ahmed,
  • Priyanka Mukherjee,
  • Ashutosh Pattanaik,
  • Avinash Badajena,
  • Minakshi Mishra,
  • Satyabrata Kanungo,
  • Sovan Sarang Dhar,
  • Dillip Kumar Parida

DOI
https://doi.org/10.1186/s43046-024-00214-6
Journal volume & issue
Vol. 36, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background The moderate deep inspiratory breath hold (mDIBH) is a modality famed for cardiac sparing. Prospective studies based on this are few from the eastern part of the world and India. We intend to compare the dosimetry between mDIBH and free-breathing (FB) plans. Methods Thirty-two locally advanced left breast cancer patients were taken up for the study. All patients received a dose of 50 Gy in 25 fractions to the chest wall/intact breast, followed by a 10-Gy boost to the lumpectomy cavity in the case of breast conservation surgery. All the patients were treated in mDIBH using active breath coordinator (ABC). The data from the two dose volume histograms were compared regarding plan quality and the doses received by the organs at risk. Paired t-test was used for data analysis. Results The dose received by the heart in terms of V5, V10, and V30 (4.55% vs 8.39%) and mean dose (4.73 Gy vs 6.74 Gy) were statistically significant in the ABC group than that in the FB group (all p-values < 0.001). Also, the dose received by the LADA in terms of V30 (19.32% vs 24.87%) and mean dose (32.99 Gy vs 46.65 Gy) were significantly less in the ABC group. The mean treatment time for the ABC group was 20 min, while that for the free-breathing group was 10 min. Conclusions Incorporating ABC-mDIBH for left-sided breast cancer radiotherapy significantly reduces the doses received by the heart, LADA, and left and right lung, with no compromise in plan quality but with an increase in treatment time.

Keywords